These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8423068)
1. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Dertzbaugh MT; Elson CO Infect Immun; 1993 Feb; 61(2):384-90. PubMed ID: 8423068 [TBL] [Abstract][Full Text] [Related]
2. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Bckström M; Holmgren J; Schödel F; Lebens M Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171 [TBL] [Abstract][Full Text] [Related]
3. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Zhang T; Li E; Stanley SL Infect Immun; 1995 Apr; 63(4):1349-55. PubMed ID: 7890393 [TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines. Dertzbaugh MT; Elson CO Infect Immun; 1993 Jan; 61(1):48-55. PubMed ID: 8418065 [TBL] [Abstract][Full Text] [Related]
5. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753 [TBL] [Abstract][Full Text] [Related]
7. Cholera toxin B subunits assemble into pentamers--proposition of a fly-casting mechanism. Zrimi J; Ng Ling A; Giri-Rachman Arifin E; Feverati G; Lesieur C PLoS One; 2010 Dec; 5(12):e15347. PubMed ID: 21203571 [TBL] [Abstract][Full Text] [Related]
8. A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers. Lesieur C; Cliff MJ; Carter R; James RF; Clarke AR; Hirst TR J Biol Chem; 2002 May; 277(19):16697-704. PubMed ID: 11877421 [TBL] [Abstract][Full Text] [Related]
9. Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. Liljeqvist S; Ståhl S; Andréoni C; Binz H; Uhlén M; Murby M J Immunol Methods; 1997 Dec; 210(2):125-35. PubMed ID: 9520296 [TBL] [Abstract][Full Text] [Related]
10. Immunologic characteristics of a Streptococcus mutans glucosyltransferase B sucrose-binding site peptide-cholera toxin B-subunit chimeric protein. Laloi P; Munro CL; Jones KR; Macrina FL Infect Immun; 1996 Jan; 64(1):28-36. PubMed ID: 8557352 [TBL] [Abstract][Full Text] [Related]
11. The binding of chimeric peptides to GM1 ganglioside enables induction of antibody responses after intranasal immunization. Delmas A; Partidos CD Vaccine; 1996 Aug; 14(11):1077-82. PubMed ID: 8879105 [TBL] [Abstract][Full Text] [Related]
12. Formulation of HIV-envelope protein with lipid vesicles expressing ganglioside GM1 associated to cholera toxin B enhances mucosal immune responses. Lian T; Bui T; Ho RJ Vaccine; 1999 Nov; 18(7-8):604-11. PubMed ID: 10547418 [TBL] [Abstract][Full Text] [Related]
13. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras. Jobling MG; Holmes RK Infect Immun; 1992 Nov; 60(11):4915-24. PubMed ID: 1399002 [TBL] [Abstract][Full Text] [Related]
14. Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin. Sultan F; Jin LL; Jobling MG; Holmes RK; Stanley SL Infect Immun; 1998 Feb; 66(2):462-8. PubMed ID: 9453596 [TBL] [Abstract][Full Text] [Related]